Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Pharma Mar SA banner

Pharma Mar SA
MAD:PHM

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
MAD:PHM
Watchlist
Price: 77.9 EUR 1.83% Market Closed
Market Cap: €1.4B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-10%
5Y
+4%
10Y
+39%
Liabilities
+
3Y
-13%
5Y
-38%
10Y
-13%
Equity
+
3Y
-7%
5Y
+101%
10Y
+145%

Balance Sheet Decomposition
Pharma Mar SA

Balance Sheet
Pharma Mar SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
10
9
7
77
37
54
37
38
37
41
30
18
22
17
8
14
24
23
18
96
113
150
60
63
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
0
0
18
96
113
122
28
26
Cash Equivalents
10
9
7
77
37
54
37
38
37
41
30
18
22
17
8
2
24
23
0
0
0
28
32
37
Short-Term Investments
81
135
124
43
102
47
61
25
26
26
19
16
6
19
38
18
8
4
3
99
89
33
103
91
Total Receivables
31
33
36
23
19
22
25
29
34
43
52
46
44
41
42
64
35
27
19
37
79
59
48
42
Accounts Receivables
31
33
36
21
17
20
24
27
33
41
50
41
38
36
40
62
31
23
11
24
51
29
27
34
Other Receivables
0
0
0
2
2
2
1
2
1
1
3
5
6
5
2
2
5
4
8
14
28
30
21
8
Inventory
7
7
9
11
10
11
19
26
24
29
25
24
22
24
23
22
24
21
9
12
11
28
39
52
Other Current Assets
1
1
0
4
3
4
7
7
5
5
3
3
1
1
2
2
2
1
1
1
4
6
3
2
Total Current Assets
129
184
176
158
170
138
150
125
126
143
130
106
96
102
112
121
93
75
50
246
295
275
253
250
PP&E Net
40
56
56
45
43
41
39
40
39
37
34
30
28
29
31
31
31
27
26
25
31
35
48
59
PP&E Gross
40
56
56
45
43
41
39
40
39
37
34
30
28
29
31
31
31
27
26
25
31
35
48
59
Accumulated Depreciation
15
17
19
19
24
27
32
34
39
42
46
46
49
49
52
55
56
54
44
47
51
50
46
47
Intangible Assets
90
133
182
11
11
11
11
12
13
14
17
20
23
26
27
25
22
17
6
4
3
3
2
1
Goodwill
8
7
5
0
0
3
3
3
3
3
3
3
3
3
3
3
3
3
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
Long-Term Investments
30
9
8
13
13
10
11
8
8
8
8
9
8
8
7
7
7
7
2
22
12
50
7
3
Other Long-Term Assets
9
7
4
20
22
22
19
20
22
26
26
33
33
26
33
34
33
30
41
33
28
31
31
36
Other Assets
8
7
5
0
0
3
3
3
3
3
3
3
3
3
3
3
3
3
0
0
0
0
0
0
Total Assets
307
N/A
395
+29%
431
+9%
247
-43%
259
+5%
224
-13%
232
+4%
208
-11%
211
+2%
231
+9%
218
-6%
200
-8%
189
-5%
194
+3%
212
+9%
221
+4%
188
-15%
158
-16%
125
-21%
330
+165%
368
+12%
393
+7%
341
-13%
350
+3%
Liabilities
Accounts Payable
18
30
22
18
21
19
23
29
30
32
28
24
24
29
32
39
37
35
19
21
27
27
29
39
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
5
21
35
52
46
41
22
24
33
63
53
55
41
44
29
28
26
28
31
17
14
15
15
10
Other Current Liabilities
6
5
7
12
13
10
11
12
9
9
9
9
8
9
10
20
19
9
10
57
45
55
52
21
Total Current Liabilities
28
55
64
81
80
69
55
65
72
103
89
87
74
83
71
87
83
72
60
95
86
97
96
83
Long-Term Debt
10
17
36
38
42
43
73
87
92
85
83
62
53
47
65
68
74
65
55
40
35
28
29
41
Deferred Income Tax
0
0
0
4
4
4
4
5
5
6
8
9
9
0
0
0
0
0
0
0
0
0
0
0
Minority Interest
1
0
0
3
1
9
3
0
0
0
5
4
4
4
4
4
4
4
4
0
0
0
0
0
Other Liabilities
3
7
15
11
4
1
1
1
1
1
3
3
4
5
3
18
8
3
2
93
69
45
22
17
Total Liabilities
42
N/A
80
+92%
115
+44%
136
+19%
131
-4%
126
-4%
137
+8%
158
+16%
170
+8%
196
+15%
178
-9%
158
-12%
136
-14%
130
-4%
135
+4%
169
+25%
161
-5%
136
-15%
113
-17%
228
+101%
190
-16%
170
-11%
147
-14%
141
-4%
Equity
Common Stock
10
10
10
10
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
Retained Earnings
70
79
82
100
138
170
215
258
281
289
288
286
275
262
0
25
51
59
70
42
121
157
142
168
Additional Paid In Capital
185
226
224
224
283
284
324
323
323
323
323
323
323
323
69
69
71
71
71
71
71
71
71
60
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
23
28
26
25
27
12
10
7
6
6
9
3
3
4
2
1
21
26
16
31
31
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
265
N/A
315
+19%
316
+0%
111
-65%
128
+16%
98
-23%
96
-3%
49
-48%
41
-17%
35
-14%
40
+12%
42
+7%
53
+26%
64
+20%
77
+20%
52
-32%
27
-49%
21
-20%
11
-47%
103
+803%
178
+73%
223
+25%
193
-13%
208
+8%
Total Liabilities & Equity
307
N/A
395
+29%
431
+9%
247
-43%
259
+5%
224
-13%
232
+4%
208
-11%
211
+2%
231
+9%
218
-6%
200
-8%
189
-5%
194
+3%
212
+9%
221
+4%
188
-15%
158
-16%
125
-21%
330
+165%
368
+12%
393
+7%
341
-13%
350
+3%
Shares Outstanding
Common Shares Outstanding
17
17
17
17
18
18
19
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18
18

See Also

Summary
PHM intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHM stock valuation using valuation multiples.
Wall Street Estimates
PHM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.